Kura Oncology (KURA) Other Non Operating Income (2015)

Kura Oncology's (KURA) quarterly Other Non Operating Income came in at $322000.0 in Q2 2015, up 51.89% on a QoQ basis from $212000.0 in Q1 2015.

Kura Oncology (KURA) Other Non Operating Income (2015) Analysis & Trends

Kura Oncology (KURA) has 1 years of Other Non Operating Income data on file, last reported at $322000.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Kura Oncology	928.19 Mn	928.19 Mn	18.00 Mn

Download Data

Date	Value
Jun 30, 2015	322,000.00
Mar 31, 2015	212,000.00